• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

BerGenBio

Selective AXL inhibitors

  • About BerGenBio
    • About BerGenBio
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Pipeline overview
    • bemcentinib | NSCLC
    • bemcentinib | COVID-19
    • bemcentinib | Melanoma
    • bemcentinib | AML
    • BGB149
    • BGB601
    • Discovery
    • Publications
    • Expanded access policy
  • Media Centre
    • News
    • Events
    • COVID-19 Media Pack
    • Media Contacts
  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts
  • Careers
  • Contact
Home  /  About BerGenBio  /  Management Team

Management Team

BerGenBio’s management team is composed of experienced biopharma executives with a drive for creating novel therapeutics for cancer. The Company’s management combine a wealth of talent and international experience in drug discovery, AXL cancer biology, and commercialisation.

Richard Godfrey (MPharmS, MBA)

Chief Executive Officer

Richard Godfrey joined BerGenBio as Chief Executive Officer in 2008.…

Read More

Professor Hani Gabra (MD, PhD, FRCPE, FRCP)

Chief Medical Officer

Professor Hani Gabra joined BerGenBio in September 2019 as Chief…

Read More

Rune Skeie

Chief Financial Officer

Rune Skeie joined BerGenBio in 2018 as CFO. He has…

Read More

James Barnes (PhD)

Director of Operations

Dr James Barnes joined BerGenBio in March 2019 and is…

Read More

Gro Gausdal (PhD)

Director of Research & Bergen Site Leader

Dr Gro Gausdal joined BerGenBio in 2013 and holds the…

Read More

Endre Kjærland (PhD)

Associate Director of IP and Contracts

Dr Endre Kjærland joined BerGenBio ASA in 2011 and is…

Read More

Debbie Molyneux

Interim HR Director

Debbie Molyneux joined the Company in 2019 as Consultant for…

Read More

Alison Messom (PhD)

Director of Clinical Operations

Dr Alison Messom joined BerGenBio in June 2019 based in…

Read More

Primary Sidebar

  • About BerGenBio
  • Management Team
  • Board of Directors
  • Partnering
  • Careers

News Subscription

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email.

We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.

Footer

Key Information

  • Pipeline
  • Investors
  • News
  • Presentations
  • Management Team

Useful Information

  • Privacy Policy
  • Terms of Use
  • Job Applicant Privacy Notice
  • Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219 688

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159

Copyright © 2017 BerGenBio ASA. All right reserved. Designed by Utopian Designs